Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Neuroendocrine × Melphalan × Clear all

Sponsor

Conditions

Multiple Myeloma 97 Lymphoma 44 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 39 Myelodysplastic Syndromes 36 Leukemia, Myeloid, Acute 36 Leukemia 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Leukemia, Lymphocytic, Chronic, B-Cell 24 Neoplasms, Plasma Cell 21 Lymphoma, Mantle-Cell 20 Lymphoma, Follicular 19 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Burkitt Lymphoma 14 Myeloproliferative Disorders 13 Immunoglobulin Light-chain Amyloidosis 13 Recurrence 12 Primary Myelofibrosis 12 Leukemia, Myeloid, Accelerated Phase 12 Hematologic Neoplasms 11 Congenital Abnormalities 11 Lymphoma, Large-Cell, Immunoblastic 10 Leukemia, Myelomonocytic, Juvenile 10 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Chronic-Phase 10 Lymphoma, T-Cell, Cutaneous 9 Blast Crisis 9 Anemia, Aplastic 9

Interventions

Everolimus 5 Bevacizumab 2 veliparib 1 pralsetinib 1 pertuzumab 1 pasireotide 1 carfilzomib 1 cabozantinib 1 berzosertib 1 Topotecan 1 Sunitinib 1 Radiotherapy 1 Radiosurgery 1 Podophyllotoxin 1 Platinum 1 Octreotide 1 Nivolumab 1 Ipilimumab 1 Etoposide 1 Cisplatin 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡